Objective 1: In this objective, the Contractor shall obtain the pure and pharmaceutical forms of codeine, morphine, oxycodone and fentanyl from DEA-certified commercial distributor(s) as well as other materials required for testing of the kit. The Contractor shall also identify parameters for the degradation of the pure and pharmaceutical forms of these drugs. Objective 2: In this objective, the Contractor shall construct a preliminary kit and monitor the progress of the reaction with the use of the pure opioid salts and actual medications. Objective 3: In this objective, the Contractor shall analyze all data and provide conclusions on the rate of disappearance of the active opioids concentration. The Contractor shall conduct additional risk assessment and product usability testing contingent upon the success of Objectives 1 and 2.

Agency
National Institute of Health (NIH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
271201300040C-0-0-1
Application #
8751075
Study Section
Project Start
2013-09-20
Project End
2014-03-19
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$149,753
Indirect Cost
Name
Innovative Chemical/Environmental Tech
Department
Type
DUNS #
781335112
City
Norwood
State
MA
Country
United States
Zip Code
02062